Shikiar Asset Management Inc Soleno Therapeutics Inc Transaction History

Shikiar Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 01, 2020	SELL	$1.64 - $3.85 $58,220 - $136,675	-35,500 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$1.35 - $2.95 $4,387 - $9,587	3,250 Added 10.08%	35,500 $104,000
Q3 2019 Oct 29, 2019	BUY	$1.5 - $2.99 $4,500 - $8,970	3,000 Added 10.26%	32,250 $48,000
Q2 2019 Jul 25, 2019	BUY	$1.93 - $2.95 $4,246 - $6,490	2,200 Added 8.13%	29,250 $82,000
Q1 2019 Apr 30, 2019	BUY	$1.35 - $2.68 $2,025 - $4,020	1,500 Added 5.87%	27,050 $56,000
Q4 2018 Feb 01, 2019	SELL	$1.55 - $2.3 $7,362 - $10,925	-4,750 Reduced 15.68%	25,550 $44,000
Q3 2018 Nov 05, 2018	BUY	$1.95 - $3.07 $39,585 - $62,321	20,300 Added 203.0%	30,300 $65,000
Q2 2018 Jul 27, 2018	BUY	$1.56 - $3.1 $15,600 - $31,000	10,000 New	10,000 $23,000

550K

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $403M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Shikiar Asset Management Inc with notifications on news.